Loading company details...
Beta
Latest Form 4 (Oct 2, 2026): Foundation Fighting Blindness Retinal Degeneration Fund (Director): Sale of 556,000 shares, $2.76M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund | Sale | 556,000 | $2.76M |
| Sep 11, 2026 | George Magrath, Chief Executive Officer | Exercise/Conversion | 392,157 | $451.0K |
| Sep 8, 2026 | Cam Gallagher | Exercise/Conversion | 784,314 | $902.0K |
| Sep 8, 2026 | Robert E. Gagnon, Chief Financial Officer | Sale | 28,000 | $127.2K |
| Jul 27, 2026 | Benjamin R. Yerxa, President | Sale | 7,429 | $22.1K |
| Jul 27, 2026 | Joseph K. Schachle, Chief Operating Officer | Sale | 4,644 | $13.7K |
| Jul 27, 2026 | George Magrath, Chief Executive Officer | Sale | 9,475 | $27.9K |
| Jul 27, 2026 | Robert E. Gagnon, Chief Financial Officer | Sale | 7,783 | $22.9K |
| May 20, 2026 | Foundation Fighting Blindness Retinal Degeneration Fund | Sale | 1,700,000 | $7.39M |
| Apr 27, 2026 | Benjamin R. Yerxa, President | Sale | 7,470 | $39.1K |